Corporate Group Health Hardens in 2026: Medical Inflation, 90%-Plus Loss Ratios and the Employer Renewal Squeeze

Health is now the largest line in Indian general insurance, and within it corporate group mediclaim is the segment repricing most sharply. The pressure is straightforward in its arithmetic: claims are rising faster than premiums were set to absorb, and insurers are pushing rate to close the gap. For an employer used to treating group health as a stable, renewable cost, 2026 is a year where the number moves, and a broker placing employee-benefit programmes has to explain why.

The headline figures frame the squeeze. Group health plan premiums grew about 10% in early 2026, slower than retail health, while overall health premiums may rise 10 to 15% on renewal. That gap, group rate growth trailing the broader health-premium increase, is itself a signal: group business is being repriced, but the underlying cost pressure is running ahead of where rates have reached.

This post reads the hardening from the broker's chair: what is driving the cost, why loss ratios have moved past the point insurers can absorb, the levers being pulled on renewal, and how to take an employer through the conversation without losing the programme.

The root driver is medical inflation, and in India it is running well ahead of general price inflation. Medical inflation is estimated at about 14% annually, and a large part of that is hospital pricing: private hospital chains are seeing a 10 to 16% rise in Average Revenue Per Occupied Bed (ARPOB), the per-bed revenue measure that captures rising charges per admission.

That distinction matters. When the cost of the same treatment rises at 14% a year, a group health programme priced on last year's claims is structurally behind before a single new claim is filed. Rising ARPOB means each hospitalisation costs the insurer more than it did, so even a stable claim frequency produces a rising claim cost. The inflation is in the price per event, not only in how often events happen.

Why this compounds for group cover

Group mediclaim is annually renewable and broadly priced, which means medical inflation feeds straight into the renewal. There is no long-tail smoothing: the prior year's elevated claim cost is the base for the next year's pricing, and the insurer adds for the inflation expected over the coming year on top. An employer that sees a double-digit rate increase is, in large part, seeing one year of medical inflation passed through plus the insurer's expectation of the next.

The second driver is what the inflation has done to insurer economics. Health insurance claims ratios have moved past 90%, meaning that for a large share of the premium earned, the money is already paid back out as claims before the insurer has met its own expenses or set anything aside.

A claims ratio above 90% is the practical reason insurers have little room to absorb the cost increase rather than pass it on. Once claims consume more than nine-tenths of earned premium, the remaining margin does not cover acquisition, administration and the cost of capital, so the only route back to a sustainable book is rate. This is why the hardening is not a negotiating posture but a financial necessity for the insurer.

For a broker, the implication is that the conversation with the insurer is more productive on structure and risk profile than on a flat plea for a lower rate. An insurer carrying a 90%-plus book will hold on price but may give ground on terms where the employer can demonstrably improve the risk, which is where the renewal levers come in.

Insurers do not price a group renewal on the market alone; they price it on the specific group. Corporate group pricing is driven by the workforce average age, the prior-year claim-to-premium ratio and the add-ons the employer has chosen, and on top of these the insurer applies an inflation loading at each yearly renewal. Each of these is a lever the broker can work.

• Workforce age rating. An older covered population claims more, so the age profile of the group directly affects the rate. Employers cannot change their demographics, but the broker can ensure the insurer is rating the actual profile rather than a conservative assumption.
• Prior-year claim experience. The claim-to-premium ratio on the group's own book is a primary input. A group with a poor prior year will see that reflected, and one with a clean year has a case for better terms.
• Inflation loading. The insurer adds a loading for expected medical inflation at renewal. Understanding how that loading is built is part of testing whether the increase is reasonable.
• Add-ons. Features such as maternity and OPD cover add cost. Reviewing which add-ons are carried, and at what sub-limits, is a direct way to manage the premium.

The levers an employer can pull on the benefit design follow from these. Co-pays and sub-limits are being tightened across the market, shifting a share of cost back to the employee or capping high-cost categories, and add-ons such as maternity and OPD are being reviewed for whether their cost is justified. Each is a way to bring the renewal number down without abandoning the programme, and each is a trade-off the broker should frame explicitly for the employer rather than apply silently.

The broker's job in 2026 is to keep the employer's programme viable through a renewal that is going to cost more, and to make the increase legible rather than arbitrary.

The starting point is to separate the market component from the group-specific component. Part of the increase is the line hardening, medical inflation near 14% and loss ratios past 90% that no employer can negotiate away, and part is the group's own age profile, claim experience and benefit design, which can be worked. An employer that understands which part of its increase is structural and which is addressable can make better decisions about where to push.

The second step is to frame the structural levers as choices. Tightening co-pays and sub-limits, reviewing maternity and OPD add-ons, and managing the workforce-age and claim-experience inputs are all ways to bring the number down, but each shifts cost or cover somewhere. The broker's value is in laying out those trade-offs clearly so the employer chooses deliberately rather than discovering a thinner programme at claim time.

Getting those decisions right depends on reading what the wordings, sub-limits and add-on terms actually do across the insurers competing for the programme, since the same headline cover can sit on very different conditions. Sarvada gives commercial insurance brokers structured, searchable access to insurer policy wordings and the intelligence around them, so an employee-benefit renewal can be structured on the real terms behind the rate rather than the headline premium alone. Request Access to ground your group health placements in the underlying wordings.